OLX 23010
Alternative Names: OLX-23010Latest Information Update: 13 Jun 2022
At a glance
- Originator OLIGOMERIX
- Class Antidementias; Small molecules
- Mechanism of Action Tau protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Dementia
Most Recent Events
- 02 Jun 2022 New profile triggered from Oligomerix pipeline, June 2022; 9359667
- 02 Jun 2022 Early research in Dementia in USA (PO) (Oligomerix pipeline, June 2022; 9359667)